Nephrocare Health Services Ltd
NSE: NEPHROPLUS | BSE: 544647
₹748.15
As on 12-Jun-2026IST
Market cap
₹7,525 Cr
Revenue (TTM)
₹756 Cr
P/E Ratio
97.9
P/B Ratio
6.7
Div. Yield
0 %
Quality Score
3/10
Growth Score
10/10
Valuation Score
5/10
Momentum Score
UNRATED/10
Stock Range
Today’s Range
52 Week Range
Liquidity
Fundamentals
-
Net Profit (TTM)
₹67 Cr
-
ROE
13.8 %
-
ROCE
14.8 %
-
Industry P/E
59.48
-
EV/EBITDA
29
-
Debt to Equity
0.4
-
Book Value
₹643.5
-
EPS
₹76
-
Face value
2
-
Shares outstanding
100,340,717
Years Aggregate
CFO
₹--
EBITDA
₹--
Net Profit
₹--
Performance
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Nephrocare Health Services
| 59.6 | 31.9 | 28.9 | -- | -- | -- | -- |
|
BSE Healthcare
| 9.1 | 1.2 | 7.9 | 7.7 | 25.1 | 13.2 | 12.3 |
Essential Checks
View DetailsIs there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Financials
View DetailsKey Ratios
View Details
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Peers
View DetailsCompany |
Price (₹) | Market Cap (₹ Cr) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Nephrocare Health Services
|
748.2 | 7,524.6 | 755.8 | 67.1 | -- | 13.8 | 97.9 | 6.7 |
| 226.8 | 554.6 | 230.1 | 23.5 | -- | 28.7 | 20.5 | 3.3 | |
| 1,601.5 | 26,830.4 | 2,762.9 | 509.8 | 22.5 | 21.5 | 53.2 | 10.7 | |
| 785.1 | 31,494.9 | 3,904.6 | 239.4 | 13.3 | 11.1 | 130.5 | 14.0 | |
| 534.3 | 1,736.8 | 772.8 | 101.5 | 15.7 | 10.7 | 17.1 | 1.8 | |
| 530.7 | 11,008.3 | 1,645.9 | 191.2 | 16.2 | 13.3 | 57.9 | 7.3 | |
| 280.9 | 891.7 | 1,319.3 | -1.5 | -4.5 | 0.3 | 758.2 | 1.4 | |
| 268.1 | 1,402.3 | 310.4 | 31.4 | 17.4 | 13.5 | 43.6 | 5.7 | |
| 528.9 | 8,414.3 | 829.0 | 162.9 | 24.5 | 29 | 51.5 | 14.5 | |
| 1,287.2 | 13,241.8 | 814.2 | 173.0 | 30.1 | 19 | 76.6 | 13.8 |
Shareholding Pattern
View DetailsNews & Analysis
All NewsAbout Nephrocare Health Services
--
-
Incorporated
2009
-
Chairman
Vikram Vuppala
-
Managing Director
Vikram Vuppala
-
Headquarters
Hyderabad, Telangana
-
Website
Looking for more details about Nephrocare Health Services Ltd’s IPO? Explore our IPO Details page.
Quarterly Updates
FAQs for Nephrocare Health Services
What is the current share price of Nephrocare Health Services Ltd Today?
The share price of Nephrocare Health Services Ltd is ₹748.15 (NSE) and ₹749.90 (BSE) as of 12-Jun-2026 IST. Nephrocare Health Services Ltd has given a return of --% in the last 1 years.
What is the current PB & PE ratio of Nephrocare Health Services Ltd?
The P/E ratio of Nephrocare Health Services Ltd is 97.92 times as on 12-Jun-2026, a 65 premium to its peers’ median range of 59.48 times.
The P/B ratio of Nephrocare Health Services Ltd is 6.74 times as on 12-Jun-2026, a 30 discount to its peers’ median range of 9.63 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2025
|
0.00
|
0.00
|
|
2024
|
0.00
|
0.00
|
|
2023
|
0.00
|
0.00
|
|
2025
|
0.00
|
0.00
|
|
2024
|
0.00
|
0.00
|
What is the 52 Week High and Low of Nephrocare Health Services Ltd?
The 52-week high and low of Nephrocare Health Services Ltd are Rs 769.75 and Rs 446.00 as of 14-Jun-2026.
What is the market cap of Nephrocare Health Services Ltd?
Nephrocare Health Services Ltd has a market capitalisation of ₹ 7,525 Cr as on 12-Jun-2026. As per SEBI classification, it is a Small Cap company.
Should I invest in Nephrocare Health Services Ltd?
Before investing in Nephrocare Health Services Ltd, assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
